000 01260 a2200337 4500
005 20250517073057.0
264 0 _c20161014
008 201610s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2015.12.067
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDey, Sougata
245 0 0 _aRole of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cFeb 2016
300 _a889-893 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBenzazepines
_xchemistry
650 0 4 _aBinding Sites
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aMolecular Docking Simulation
650 0 4 _aPhenols
_xchemistry
650 0 4 _aPiperidines
_xchemistry
650 0 4 _aProtein Structure, Tertiary
650 0 4 _aReceptors, N-Methyl-D-Aspartate
_xantagonists & inhibitors
650 0 4 _aTritium
_xchemistry
700 1 _aSchepmann, Dirk
700 1 _aWünsch, Bernhard
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 26
_gno. 3
_gp. 889-893
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2015.12.067
_zAvailable from publisher's website
999 _c25616237
_d25616237